Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBANDRONATE for Bone density abnormal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where IBANDRONATE was used for Bone density abnormal.

Most Reported Side Effects for IBANDRONATE

Side Effect Reports % Deaths Hosp.
Femur fracture 990 9.7% 12 667
Arthralgia 975 9.6% 60 140
Pain 779 7.7% 18 110
Pain in extremity 726 7.1% 6 152
Back pain 688 6.8% 12 129
Myalgia 623 6.1% 52 32
Diarrhoea 551 5.4% 60 46
Low turnover osteopathy 521 5.1% 8 343
Nausea 480 4.7% 30 54
Anxiety 456 4.5% 5 257
Bone pain 439 4.3% 2 34
Headache 437 4.3% 55 40
Fall 427 4.2% 69 244
Osteonecrosis of jaw 422 4.2% 11 104
Dyspepsia 408 4.0% 1 27

Other Indications for IBANDRONATE

Product used for unknown indication (4,506) Osteoporosis (4,121) Osteopenia (915) Osteoporosis postmenopausal (103) Osteoporosis prophylaxis (102) Bone disorder (67) Breast cancer (57) Bone density decreased (54) Bone loss (54) Breast cancer metastatic (48)

Other Drugs Used for Bone density abnormal

DENOSUMAB (621) TERIPARATIDE (139) ALENDRONATE (129) ABALOPARATIDE (70) ZOLEDRONIC ACID (59) RISEDRONATE (47) ALENDRONIC ACID (18) ADALIMUMAB (17) ROMOSOZUMAB-AQQG (15) ETANERCEPT (14)

Related Pages

IBANDRONATE Full Profile All Bone density abnormal Drugs IBANDRONATE Demographics IBANDRONATE Timeline